QUIDELORTHO CORP APIC, Share-based Payment Arrangement, Increase for Cost Recognition
QUIDELORTHO CORP (QDEL) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $12.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-07
- QUIDELORTHO CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-28 was $12.00M, a 5.51% decline year-over-year.
- QUIDELORTHO CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-29 was $10.70M, a 6.14% decline year-over-year.
- QUIDELORTHO CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-28 was $10.60M, a 11.67% decline year-over-year.
- QUIDELORTHO CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-29 was $12.70M, a 23.30% increase year-over-year.
- QUIDELORTHO CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $45.50M, a 10.98% increase from fiscal 2024.
- QUIDELORTHO CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $41.00M, a 19.45% decline from fiscal 2023.
- QUIDELORTHO CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $50.90M, a 12.86% increase from fiscal 2023.
- QUIDELORTHO CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $45.10M, a 98.68% increase from fiscal 2022.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-28 | $12.00M 10-Q · filed 2026-08-07 | $22.70M derived: sum of 2 quarters · filed 2026-08-07 | ||
| 2026-03-29 | $10.70M 10-Q · filed 2026-08-07 | |||
| 2025-12-28 | $45.50M 10-K · filed 2026-02-19 | |||
| 2025-09-28 | $10.60M 10-Q · filed 2025-11-06 | $23.30M derived: sum of 2 quarters · filed 2026-08-07 | $34.70M derived: sum of 3 quarters · filed 2026-08-07 | |
| 2025-06-29 | $12.70M 10-Q · filed 2026-08-07 | $24.10M derived: sum of 2 quarters · filed 2026-08-07 | ||
| 2025-03-30 | $11.40M 10-Q · filed 2026-08-07 | |||
| 2024-12-29 | $41.00M 10-K · filed 2026-02-19 | |||
| 2024-09-29 | $12.00M 10-Q · filed 2025-11-06 | $22.30M derived: sum of 2 quarters · filed 2025-11-06 | $31.30M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $10.30M 10-Q · filed 2025-11-06 | $19.30M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $9.00M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $50.90M 10-K · filed 2026-02-19 | |||
| 2023-10-01 | $13.50M 10-Q · filed 2024-11-08 | $27.20M derived: sum of 2 quarters · filed 2024-11-08 | $37.60M derived: sum of 3 quarters · filed 2024-11-08 | |
| 2023-07-02 | $13.70M 10-Q · filed 2024-11-08 | $24.10M derived: sum of 2 quarters · filed 2024-11-08 | ||
| 2023-04-02 | $10.40M 10-Q · filed 2024-11-08 | |||
| 2023-01-01 | $45.10M 10-K · filed 2025-02-27 | |||
| 2022-10-02 | $12.60M 10-Q · filed 2023-11-02 | $27.30M derived: sum of 2 quarters · filed 2023-11-02 | $33.50M derived: sum of 3 quarters · filed 2023-11-02 | |
| 2022-07-03 | $14.70M 10-Q · filed 2023-11-02 | $20.90M derived: sum of 2 quarters · filed 2023-11-02 | ||
| 2022-04-03 | $6.20M 10-Q · filed 2023-11-02 | |||
| 2022-01-02 | $22.70M 10-K/A · filed 2024-08-01 | |||
| 2021-10-03 | $5.60M 10-Q · filed 2022-11-04 | $11.40M derived: sum of 2 quarters · filed 2022-11-04 | $17.30M derived: sum of 3 quarters · filed 2022-11-04 | |
| 2021-07-04 | $5.80M 10-Q · filed 2022-11-04 | $11.70M derived: sum of 2 quarters · filed 2022-11-04 | ||
| 2021-04-04 | $5.90M 10-Q · filed 2022-11-04 | |||
| 2021-01-03 | $19.00M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |